Have you Secured your Clinical Target Engagement Assay?

Harness CETSA® for Target Engagement in Whole Blood Validate target engagement with CETSA to link your drug’s mechanism of action to clinical outcomes. This application note highlights how CETSA’s matrix-agnostic technology ensures consistency from preclinical to clinical phases, enabling robust assessments in whole blood. Discover how collaborations with industry leaders like AbbVie demonstrate CETSA’s for use with fresh and frozen blood samples. Explore its applications for key targets like RIPK1 and Akt, supporting dose monitoring and clinical accessibility.   Download now to learn how CETSA can streamline target engagement studies and strengthen your clinical development strategy.